{ "cik": 1583107, "cik_padded": "0001583107", "entityName": "Theravance Biopharma, Inc.", "fiscal_years": [ { "accn": "0001104659-26-033077", "filed": "2026-03-23", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 42000.0, "cash": 167806000.0, "eps_diluted": 2.06, "free_cash_flow": 238499000.0, "net_income": 105895000.0, "operating_cash_flow": 238541000.0, "operating_income": -3602000.0, "revenue": 107464000.0, "stockholders_equity": 296723000.0, "total_assets": 485570000.0 }, "period_end": "2025-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": 0.9853997617806894, "operating_margin": -0.03351820144420457, "revenue_growth_yoy": 0.6691881145058325, "roa_avg2y": 0.25221172018182014, "roa_period_end": 0.21808390139423767, "roe_avg2y": 0.4484529970271117, "roe_period_end": 0.35688167078386246 } }, { "accn": "0001104659-26-033077", "filed": "2026-03-23", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 445000.0, "capex": 332000.0, "cash": 37797000.0, "eps_diluted": -1.15, "free_cash_flow": -11867000.0, "net_income": -56418000.0, "operating_cash_flow": -11535000.0, "operating_income": -46949000.0, "revenue": 64381000.0, "stockholders_equity": 175545000.0, "total_assets": 354161000.0 }, "period_end": "2024-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -0.8763144405958279, "operating_margin": -0.7292368866591075, "revenue_growth_yoy": 0.12115143494009474, "roa_avg2y": -0.15327646163877418, "roa_period_end": -0.15930043115983974, "roe_avg2y": -0.29041025377052554, "roe_period_end": -0.32138767837306675 } }, { "accn": "0001558370-25-002447", "filed": "2025-03-07", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 197051000.0, "capex": 2488000.0, "cash": 39545000.0, "eps_diluted": -1.0, "free_cash_flow": -29485000.0, "net_income": -55193000.0, "operating_cash_flow": -26997000.0, "operating_income": -56035000.0, "revenue": 57424000.0, "stockholders_equity": 212995000.0, "total_assets": 381999000.0 }, "period_end": "2023-12-31", "ratio_units": { "net_margin": "ratio", "operating_margin": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "net_margin": -0.9611486486486487, "operating_margin": -0.9758115073836723, "roa_avg2y": -0.11156874021501942, "roa_period_end": -0.14448467142584143, "roe_avg2y": -0.16858100626913766, "roe_period_end": -0.25912814854808797 } }, { "accn": "0001558370-25-002447", "filed": "2025-03-07", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "buybacks": 128830000.0, "capex": 572000.0, "cash": 298172000.0, "eps_diluted": 11.85, "free_cash_flow": -187563000.0, "net_income": 872132000.0, "operating_cash_flow": -186991000.0, "operating_income": -91957000.0, "stockholders_equity": 441800000.0, "total_assets": 607400000.0 }, "period_end": "2022-12-31", "ratio_units": { "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_avg2y": 1.7758402148604333, "roa_period_end": 1.4358445834705302, "roe_avg2y": 16.89736212425044, "roe_period_end": 1.9740425531914894 } }, { "accn": "0001558370-24-002267", "filed": "2024-03-01", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 3406000.0, "cash": 89959000.0, "eps_diluted": -2.87, "free_cash_flow": -211264000.0, "net_income": -199426000.0, "operating_cash_flow": -207858000.0, "operating_income": -257784000.0, "revenue": 55311000.0, "stockholders_equity": -338573000.0, "total_assets": 374819000.0 }, "period_end": "2021-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.230262883226408, "roa_avg2y": -0.472642900141727, "roa_period_end": -0.5320594740394697, "roe_avg2y": 0.6209514201555602 } }, { "accn": "0001558370-23-002595", "filed": "2023-03-01", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 6616000.0, "cash": 81467000.0, "eps_diluted": -4.46, "free_cash_flow": -257019000.0, "net_income": -278017000.0, "operating_cash_flow": -250403000.0, "operating_income": -297627000.0, "revenue": 71857000.0, "stockholders_equity": -303751000.0, "total_assets": 469057000.0 }, "period_end": "2020-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": -0.021208488844089685, "roa_avg2y": -0.6333805302073283, "roa_period_end": -0.5927147446898777, "roe_avg2y": 1.0539110788470614 } }, { "accn": "0001558370-23-002595", "filed": "2023-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 3176000.0, "cash": 58064000.0, "eps_diluted": -4.25, "free_cash_flow": -241373000.0, "net_income": -236455000.0, "operating_cash_flow": -238197000.0, "operating_income": -251915000.0, "revenue": 73414000.0, "stockholders_equity": -223840000.0, "total_assets": 408826000.0 }, "period_end": "2019-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 0.21606758323670697, "roa_avg2y": -0.48800849482127545, "roa_period_end": -0.5783756414709437, "roe_avg2y": 1.7169942162953067 } }, { "accn": "0001558370-22-002373", "filed": "2022-02-28", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 7240000.0, "cash": 378021000.0, "free_cash_flow": -120107000.0, "net_income": -215524000.0, "operating_cash_flow": -112867000.0, "operating_income": -238751000.0, "revenue": 60370000.0, "stockholders_equity": -51589000.0, "total_assets": 560235000.0 }, "period_end": "2018-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "revenue_growth_yoy": 2.9236968672819446, "roa_avg2y": -0.43034438692737376, "roa_period_end": -0.3847028479120369, "roe_avg2y": -6.778656685904795 } }, { "accn": "0001558370-21-002006", "filed": "2021-02-26", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 2406000.0, "cash": 88980000.0, "free_cash_flow": -203458000.0, "net_income": -285405000.0, "operating_cash_flow": -201052000.0, "operating_income": -260123000.0, "revenue": 15386000.0, "stockholders_equity": 115178000.0, "total_assets": 441400000.0 }, "period_end": "2017-12-31", "ratio_units": { "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "revenue_growth_yoy": -0.6837280052622924, "roa_avg2y": -0.5282079185382185, "roa_period_end": -0.6465903942002719, "roe_avg2y": -1.2264696213438073, "roe_period_end": -2.477947177412353 } }, { "accn": "0001558370-20-001644", "filed": "2020-02-27", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 2135000.0, "cash": 344709000.0, "free_cash_flow": -101124000.0, "net_income": -190669000.0, "operating_cash_flow": -98989000.0, "operating_income": -180467000.0, "revenue": 48648000.0, "stockholders_equity": 350231000.0, "total_assets": 639254000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_period_end": -0.29826798111548775, "roe_period_end": -0.5444092613161028 } } ], "latest_filing": { "accn": "0001104659-26-033077", "filed": "2026-03-23", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001583107.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001583107.json" }, "ticker": "TBPH" }